Tucuvi continues its internationalization. The Spanish company specializes in digital healthwhich operates with virtual clinical assistants to monitor and control patients, landed in the UK, a country where they have introduced remote user monitoring technology via phone call, according to Marcos Rubio, co-founder of Tucuvi, explained to PlantTwelve.

To deploy its technology in the UK, Tucuvi has started working with Cera, a home health service provider, which monitors chronic patients in hospitals in the UK.

Cera’s technology is used by hundreds of care companies offering more than one million in-home appointments per week. The goal of this tool is to reduce hospitalization and readmission rates. Rubio also acknowledged that Tucuvi had begun negotiations with the British health system, the NHS, to expand its services in the country. One of the company’s future goals is to make the jump to the United States, a plan it plans to make next year, according to Rubio.

Tucuvi operates in Portugal through an agreement with CUF Cascais Hospital

The company is present in Spain, England and Portugal. In the latter country, the attack took place at the beginning of the year, through an agreement with CUF Cascais Hospital. Those in charge of the medical center trusted the Spanish company to carry out follow-up after discharge without overburdening the clinical team.

If the virtual assistant detects signs of alarm, the clinical team will be notified and take action. The project in Portugal is promoted by the innovation team, operational transformation office and nursing of CUF Cascais Hospital.

Tucuvi is a health technology Madrid founded in 2019 which has created the virtual assistant Lola to adapt the monitoring of each patient from their home. To date, the company has managed more than one million conversations and the technology frees up up to 70% of the care team’s time and reduces the average length of hospital stay by 26%.

The company received 5.5 million euros from the European Commission at the end of 2022

Last summer, Tucuvi closed a financing round of 800,000 euros where several people participate business angel and a Portuguese fund linked to the technology sector, whose name was not disclosed.

Additionally, at the end of 2022, the company received €5.5 million from the European Commission under the EIC Accelerator. Of the total amount, 2.5 million euros are in the form of non-refundable subsidies and three million euros of investment through the EIC Fund, which will strengthen Tucuvi’s commercial activities.

The resources obtained allowed Tucuvi to start the development of “project Lola version 2.0”, in addition to making the tool available in more than twenty languages.

The founders of Tucuvi are Marcos Rubio María Gónzalez and Marcos Rubio, two biomedical engineers, who controlled most of the capital. González had an idea for that stub when he worked at Medtronic, an American multinational company specializing in this sector medical technology.